Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Medicines Co. Falls on Angiomax Woes
Yahoo/Zacks.com
Wednesday, April 2, 2014 - 9:51pm
tags:
Angiomax, The Medicines Company, patents
IPO Preview: Scynexis
Seeking Alpha
Wednesday, April 2, 2014 - 9:46pm
tags:
IPOs, Scynexis, anti-infectives
Sanofi eyes more acquisitions, sees growth in Africa
Yahoo/Reuters
Wednesday, April 2, 2014 - 9:44pm
tags:
Sanofi, Africa, M&A, Chris Viehbacher
IPO Preview: Corium International
Seeking Alpha
Wednesday, April 2, 2014 - 9:42pm
tags:
IPOs, Corium International, transdermal drug delivery
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wednesday, April 2, 2014 - 9:41pm
tags:
Sovaldi, hepatitis C, Gilead Sciences
Myriad shares soar after Medicare reimbursements get a 37% boost
Marketwatch
Wednesday, April 2, 2014 - 9:40pm
tags:
Medicare, Myriad Genetics
FDA defends generic drug label proposal at U.S. House hearing
Yahoo/Reuters
Wednesday, April 2, 2014 - 7:48am
tags:
FDA, generics, labeling
Can MannKind Shares Double Again on FDA Approval?
24/7 Wall St
Wednesday, April 2, 2014 - 7:46am
tags:
FDA, Afrezza, diabetes, MannKind
A Second Lawsuit Tests the BPCIA Biosimilars “Patent Dance” Waters
FDA Law Blog
Wednesday, April 2, 2014 - 7:45am
tags:
patents, biosimilars, Celltrion, Janssen Biotech, Remicade
Danone-Mead Johnson Would Make Baby Food Giant: Real M&A
Bloomberg
Wednesday, April 2, 2014 - 7:33am
tags:
Danone, Mead Johnson, infant nutrition, M&A
Illumina Expands Product Portfolio to Support Oncology Clinical Research and Discovery
Yahoo
Wednesday, April 2, 2014 - 7:31am
tags:
Illumina, oncology, drug discovery, next-generation gene sequencing
Europe Moves to Make Drug Trial Data More Transparent
Bloomberg/Businessweek
Wednesday, April 2, 2014 - 7:29am
tags:
Europe, clinical trial data, transparency
Boston Scientific reports favorable results in MADIT-CRT study
Yahoo/Fly on the Wall
Wednesday, April 2, 2014 - 7:28am
tags:
devices, Boston Scientific, cardiac resynchronization therapy, platinum chromium stent platforms, TAVR
GlaxoSmithKline throws in towel on lung cancer vaccine trial
Yahoo/Reuters
Wednesday, April 2, 2014 - 7:26am
tags:
GSK, vaccines, non-small cell lung cancer, MAGE-A3
Biotech Auxilium Boosts Position In Men's Health Care
Investors.com
Wednesday, April 2, 2014 - 7:25am
tags:
Auxilium, erectile dysfunction, testosterone
Covidien's Ablation System: A Sure Winner
Yahoo/Zacks.com
Wednesday, April 2, 2014 - 7:23am
tags:
Covidien, devices, Barrett's esophagus, Barrx RF Ablation System
Academic health leaders paid big bucks on industry boards; conflicts of interest, study asks?
Yahoo/AP
Wednesday, April 2, 2014 - 7:20am
tags:
pharma industry
Pacira Up as Exparel Site Gets FDA Nod
Yahoo/Zacks.com
Wednesday, April 2, 2014 - 7:19am
tags:
Pacira, EXPAREL, FDA
Stallergenes gains U.S. FDA approval for Oralair allergy drug
Yahoo/Reuters
Tuesday, April 1, 2014 - 10:25pm
tags:
Stallergenes, FDA, Oralair
GSK's ViiV unit adds new HIV drug to AIDS patent pool
Yahoo/Reuters
Tuesday, April 1, 2014 - 10:21pm
tags:
GSK, ViiV, AIDS, patents

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.